SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NEAR Protocol is the blockchain for AI. A high-performance, AI-native platform built to power the next generation of decentralized applications and intelligent agents. It provides the infrastructure AI needs to transact, operate, and interact across Web2 and Web3. NEAR combines three core elements: User-Owned AI, which ensures agents act in users’ best interests; Intents and Chain Abstraction, which eliminate blockchain complexity for seamless, goal-driven transactions across chains; and a sharded blockchain architecture that delivers the scalability, speed, and low-cost execution needed for real-world AI and Web3 use. This integrated stack makes NEAR the foundation for building secure, user-owned, AI-native applications at internet scale.

Near

NEAR is drawing attention after traders linked its sharp rally to the launch of confidential perpetual contracts powered by Hyperliquid, bringing privacy to leveraged on-chain trading. The community is broadly bullish on NEARs AI, privacy, and cross-chain infrastructure narrative, while some traders attribute the move to momentum, short liquidations, or a liquidity-driven pump rather than a fundamental catalyst.

StarkNet is a permissionless decentralized Layer 2 (L2) validity rollup, built to allow Ethereum to scale via cryptographic protocols called STARKs, without compromising Ethereum’s core principles of decentralization, transparency, inclusivity and security. The StarkNet Token is needed to operate the ecosystem, maintain and secure it, decide on its values and strategic goals, and direct its evolution. This token will be required for (i) governance, (ii) payment of transaction fees on StarkNet, and (iii) participation in StarkNet’s consensus mechanism.

Starknet

Attention is centered on Starknets privacy and BTCFi push, particularly the rollout of strkBTC and STRK20, which traders say could enable shielded Bitcoin and ERC-20 transactions alongside staking and DeFi use. The community is broadly optimistic about Starknets ZK and post-quantum technology, though some traders remain concerned about token unlocks, dilution, and the tokens weak longer-term chart.

Critical Metals Corp. engages in the mining, exploration, and development of lithium metals. It owns Wolfsberg Project and Tanbreez Project. The company was founded on October 24, 2022 and is headquartered in British Virgin Islands.

Critical Metals Corp.

A reported U.S.-Denmark-Greenland security agreement has focused attention on CRMLs Tanbreez heavy rare-earth project, with traders viewing tighter limits on Chinese and Russian access to Greenland as a strategic-sector tailwind. The community is broadly bullish and expects short-covering, although skeptics note the agreement does not directly fund Tanbreez or change its development timeline, making the move partly sentiment- and squeeze-driven.

Tema ETF Trust - Tema Space Innovators ETF

Tema Space Innovators ETF

SpaceXs public-market debut, subsequent selloff, and anticipated lockup-related selling have pressured NASA through its sizable SpaceX exposure and weighed on the broader space ETF sector. Traders debate whether the decline reflects poor ETF management and concentrated holdings or a long-term accumulation opportunity, with bearish holders citing continued weakness while bullish investors average down.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trumps escalating Iran standoffspanning speculation about renewed strikes, negotiations, and the Strait of Hormuzis driving attention, with traders linking the conflict to oil prices, inflation, and broader market risk. Supporters frame the developments as strategic pressure and security policy, while critics focus on war costs, rising fuel prices, and potential economic damage.

Avalanche is a high throughput smart contract blockchain&nbsp;platform. Validators secure the network through a proof-of-stake consensus protocol. It is said to be fast, low cost, and environmental friendly.

Avalanche

A sharp AVAX rally accompanied by heavy volume has focused attention on Avalanches institutional and real-world-asset tokenization narrative, including trader claims about NYSE testing and expanded brokerage access. The community is split between bullish momentum and adoption views and skepticism that the move is a temporary pump, citing weak follow-through, token inflation, and limited fee revenue.

Harvest Portfolios Group Inc - Harvest Diversified High Income Shares ETF (Class A Units)

Discussion centers on HHIS as a diversified, tax-efficient high-income ETF offering monthly distributions through covered calls and modest leverage, with renewed attention from income-focused investors and ETF-content promotion. Traders are broadly positive about reinvesting distributions and diversification, while some question distribution sustainability, leverage, and potential net-asset-value erosion during technology-sector weakness.

Zcash is a privacy-focused cryptocurrency that uses trustless zero-knowledge proofs to enable fully encrypted transactions while maintaining blockchain transparency and security. It was the first cryptocurrency to implement zero-knowledge encryption for private peer-to-peer payments, addressing the fundamental privacy gap in traditional cryptocurrencies that expose transaction details publicly.   With a fixed supply of 21 million ZEC and a halving schedule similar to Bitcoin, Zcash allows users to prove transactions are valid without revealing sensitive information like wallet balances, transaction amounts, or participant identities, making it suitable for everyday payments, long-term savings, and cross-border money transfers where financial confidentiality matters.  The protocol operates on its own blockchain currently using Proof-of-Work consensus, though it's evolving toward Proof-of-Stake through the planned "Crosslink" upgrade to enhance security, scalability, and energy efficiency. Zcash employs trustless zero-knowledge proofs (Halo) within its Orchard shielded pool to verify transactions without revealing sender, receiver, or amount information.   Users can choose between transparent public transactions and shielded private transactions through Unified Addresses, which work with both types. The network is faster and cheaper than Bitcoin, with new blocks mined every 75 seconds and transaction fees typically just a fraction of a cent. Privacy adoption has surged in 2025, with over 30% of total ZEC supply now held in fully shielded pools.  Zcash was created by a group of scientists in 2013 who initially proposed Zerocoin as a privacy extension to Bitcoin before building a standalone protocol. The ecosystem operates with a self-funded development model where block rewards support independent teams through the Zcash Community Grants Committee and a new Coinholder-Controlled Fund.

Zcash

Zcash is drawing attention after an explosive rally to new highs, with traders citing renewed demand for privacy-focused crypto, limited supply, the Grayscale Zcash ETFs announced 3-for-1 split, and short liquidations. Bulls view the move as a broader privacy-coin breakout, while skeptics attribute it largely to FOMO and warn of a sharp pullback.

Sui s a Layer 1 blockchain developed by Mysten Labs, a team founded by former lead engineers from Meta’s blockchain research division. It is designed for global adoption by providing a secure, high-speed environment for digital asset ownership and removing technical barriers for Web3 applications. The platform utilizes the Move programming language to create a safe framework and supports horizontal scaling to keep fees stable and speeds high as the network grows. Significant institutional support comes from major venture capital firms including Andreessen Horowitz, Coinbase Ventures, Circle Ventures, and YZi Labs.  The system functions by organizing data into independent objects rather than a single ledger of accounts. This object-centric data model enables parallel execution, allowing the network to process many transactions simultaneously instead of waiting for one to finish before starting the next. This architecture is built for rapid transaction finalization to ensure near-instant results. To maintain long-term stability, the network collects fees into a storage fund that rewards validators for keeping data on the network indefinitely.  Sui offers several advanced tools including zkLogin for easier account access and sponsored transactions that allow users to interact with apps without managing complex wallets or immediate fees. Developers can also create tailored object types that work across the entire network, which encourages innovation and deep composability. These features are designed to create a more user-friendly experience for interacting with decentralized applications and digital games.  The SUI token is central to the ecosystem, serving as the primary asset for transaction fees and on-chain utility within decentralized exchanges and lending platforms. Users participate in a proof-of-stake mechanism by locking their tokens to support validators and secure the blockchain in exchange for rewards. Additionally, token holders have a role in governance, allowing them to participate in voting on network rules and future protocol upgrades. Value moves through the system through these staking rewards and transaction fees to ensure the platform scales sustainably

Reported Sui mainnet outages and network stalls are the dominant catalyst, renewing concerns about reliability, asset freezes, and the protocols prior exploit history. Traders are divided between treating the disruptions and token unlock supply as bearish risks and viewing the selloff as a buying opportunity tied to Suis gasless stablecoin-transfer and institutional-adoption narrative.

Kura Oncology, Inc. operates as a clinical-stage biopharmaceutical company, which engages in the research and development of medicines for the treatment of cancer. Its pipeline includes Tipifarnib, which is a Farnesyl transferase inhibitor for HRAS Mutant Solid Tumors, Chronic Myelomonocytic Leukemia, KO-947, which is an ERK inhibitor for MAPK Pathway Tumors, and KO-539, which is a Menin MLL inhibitor for acute leukemias. The company was founded by Troy E. Wilson, Yi Liu, Pingda Ren and Antonio Gualberto on August 22, 2014 and is headquartered in San Diego, CA.

Kura Oncology Inc

Kura Oncology is trending as investors digest the achievement of a major commercial milestone involving a substantial milestone payment, alongside active discussion regarding upcoming clinical trial data presentations at ASH and the company's frontline AML expansion strategy. While sentiment is largely bullish, some traders are expressing frustration over recent price volatility and the stock's performance relative to its peers.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

aTyr Pharma (ATYR) Projected to Post Earnings on Wednesday

aTyr Pharma (NASDAQ:ATYR) will be releasing its Q1 2026 earnings before the market opens on Wednesday, May 6. (View Earnings Report at...

aTyr Pharma, Inc. (NASDAQ:ATYR) Given Average Recommendation of "Hold" by Brokerages

Shares of aTyr Pharma, Inc. (NASDAQ:ATYR - Get Free Report) have been assigned an average recommendation of "Hold" from the seven research firms that are covering the stock, Marketbeat Ratings...

aTyr Pharma, Inc. (NASDAQ:ATYR) Given Average Recommendation of "Hold" by Analysts

aTyr Pharma, Inc. (NASDAQ:ATYR - Get Free Report) has been given a consensus recommendation of "Hold" by the seven research firms that are currently covering the stock, MarketBeat reports. One equities research analyst has rated the stock with a sell recommendation, five have issued a hold recomm...

aTyr Pharma (NASDAQ:ATYR) Upgraded at Wall Street Zen

Wall Street Zen raised shares of aTyr Pharma from a "sell" rating to a "hold" rating in a research note on Sunday...

aTyr Pharma Spotlights Efzofitimod Phase 3 Learnings, Eyes Mid-April FDA Type C Meeting

aTyr Pharma (NASDAQ:ATYR) CEO Sanjay Shukla outlined the company's strategy to develop new therapies for inflammation and fibrosis based on tRNA synthetase biology during a presentation at the...

Q1 Earnings Estimate for aTyr Pharma Issued By HC Wainwright

aTyr Pharma, Inc. (NASDAQ:ATYR - Free Report) - Analysts at HC Wainwright issued their Q1 2026 earnings per share estimates for shares of aTyr Pharma in a research report issued on Friday, March 6th...

ATYR PHARMA INC Q4 Loss Drops

(RTTNews) - aTYR PHARMA INC (ATYR) reported Loss for fourth quarter of -$13.96 million...

aTyr Pharma (NASDAQ:ATYR) Posts Quarterly Earnings Results, Beats Expectations By $0.04 EPS

aTyr Pharma (NASDAQ:ATYR - Get Free Report) issued its quarterly earnings results on Thursday. The company reported ($0.14) EPS for the quarter, beating analysts' consensus estimates of ($0.18) by...

aTyr Pharma (ATYR) Expected to Announce Quarterly Earnings on Thursday

aTyr Pharma (NASDAQ:ATYR) will be releasing its Q4 2025 earnings before the market opens on Thursday, March 12. (View Earnings Report at...

aTyr Pharma, Inc. (NASDAQ:ATYR) Given Consensus Recommendation of "Hold" by Analysts

Shares of aTyr Pharma, Inc. (NASDAQ:ATYR - Get Free Report) have been assigned an average recommendation of "Hold" from the seven brokerages that are presently covering the company, MarketBeat.com...

aTyr Pharma, Inc. engages in the discovery and development of medicines based on novel biological pathways. Its product pipeline includes ATYR1923, ATYR2810, NRP2 mAbs, and AARS-1, DARS-1. The company was founded by Paul Schimmel, Xiang-Lei Yang and Bruce Beutler on September 8, 2005 and is headquartered in San Diego, CA.

Atyr Pharma Inc

Why Is aTyr Stock Falling Today?

Equity

Bullish Sentiment

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Current Price	$0.363
Prev Close	$0.3765
Open	$0.37
Dividend Yield	0.00%
50-Day Moving Average	$0.4949
Beta	1.04
Avg. Volume	617,899.36
PE Ratio	-0.58

52-Week High	$1.12
52-Week Low	$0.36
Market Capitalization	$35.61M
EPS (Annual)	-$0.7971
Price to Book	0.73
Revenue Per Employee	$3,275.86

Feed

News

Sentiment

Earnings

Fundamentals

Info

ATYR Fundamentals